Comparison of MAX-ACT and K-ACT values when using bivalirudin anticoagulation during minimally invasive hybrid off-pump coronary artery bypass graft surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 3, 2011, Pages 415-418

  Jones, Philip M ^a   Bainbridge, Daniel ^a   Dobkowski, Wojciech ^a   Harle, Christopher C ^a   Murkin, John M ^a   Fernandes, Philip S ^b   Kiaii, Bob ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

activated coagulation time; anticoagulation; assay; bivalirudin

Indexed keywords

GLASS; HIRULOG; INFUSORIAL EARTH; KAOLIN;

ACTIVATED COAGULATION TIME; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; OFF PUMP CORONARY SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

BLOOD COAGULATION; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HIRUDINS; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; WHOLE BLOOD COAGULATION TIME;

EID: 79957760668     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.12.007     Document Type: Article

References (19)

1. Hattersley PG: Activated coagulation time of whole blood. JAMA 196:436-440, 1966
2. Prisco D, Paniccia R: Point-of-care testing of hemostasis in cardiac surgery. Thromb J 1:1, 2003
3. Merry AF, Raudkivi PJ, Middleton NG, et al: Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 77:925-931, 2004 (Pubitemid 38271062)
4. Smedira NG, Dyke CM, Koster A, et al: Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: The results of the EVOLUTION-OFF study. J Thorac Cardiovasc Surg 131:686-692, 2006
5. Dyke CM, Smedira NG, Koster A, et al: A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study. J Thorac Cardiovasc Surg 131:533-539, 2006
6. Koster A, Dyke CM, Aldea G, et al: Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: Results of the CHOOSE-ON trial. Ann Thorac Surg 83:572-577, 2007 (Pubitemid 46156924)
7. Yavari M, Becker RC: Anticoagulant therapy during cardiopulmonary bypass. J Thromb Thrombolysis 26:218-228, 2008
8. Kiaii B, McClure RS, Stewart P, et al: Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. J Thorac Cardiovasc Surg 136:702-708, 2008
9. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327:307-310, 1986 (Pubitemid 16134762)
10. Wasowicz M, Vegas A, Borger MA, et al: Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. Can J Anaesth 52:1093-1098, 2005 (Pubitemid 43192567)
11. Leissner KB, Ketchedjian A, Crowley R, et al: Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome. J Card Surg 22:78-82, 2007 (Pubitemid 46110430)
12. Koster A, Spiess B, Jurmann M, et al: Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: Results of the "EVOLUTION OFF" trial. Anesth Analg 103:540-544, 2006
13. Dyke CM, Aldea G, Koster A, et al: Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies. Ann Thorac Surg 84:836-839, 2007 (Pubitemid 47285016)
14. Koster A, Chew D, Gründel M, et al: Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesth Analg 96:383-386, 2003 (Pubitemid 36125750)
15. Zucker ML, Koster A, Prats J, et al: Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery. J Extra Corpor Technol 37:364-368, 2005 (Pubitemid 351506611)
16. Machin D, Devine P: The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement. J Extra Corpor Technol 37:265-271, 2005 (Pubitemid 43160405)
17. Leyvi G, Shore-Lesserson L, Harrington D, et al: An investigation of a new activated clotting time "MAX-ACT" in patients undergoing extracorporeal circulation. Anesth Analg 92:578-583, 2001
18. Koster A: OPCAB: Which kind of anticoagulation? Eur J Anaesthesiol 24:77-82, 2007
19. FitzGibbon GM, Burton JR, Leach AJ: Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and of 1132 after one year. Circulation 57:1070-1074, 1978 (Pubitemid 8343620)